bioMérieux Stock Euronext Paris
Equities
FR0010096479
Medical Equipment, Supplies & Distribution
Sales 2024 * | 3.91B 4.16B | Sales 2025 * | 4.19B 4.46B | Capitalization | 11.7B 12.44B |
---|---|---|---|---|---|
Net income 2024 * | 471M 501M | Net income 2025 * | 529M 563M | EV / Sales 2024 * | 2.9 x |
Net cash position 2024 * | 348M 371M | Net cash position 2025 * | 590M 628M | EV / Sales 2025 * | 2.65 x |
P/E ratio 2024 * |
25.4
x | P/E ratio 2025 * |
22.6
x | Employees | - |
Yield 2024 * |
0.88% | Yield 2025 * |
0.98% | Free-Float | 35.51% |
Latest transcript on bioMérieux
Managers | Title | Age | Since |
---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 52 | 16-10-31 |
Chairman | 50 | 04-04-15 | |
Director of Finance/CFO | 47 | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 06-09-14 | |
Director/Board Member | 63 | 04-12-31 | |
Chairman | 50 | 04-04-15 |
1st Jan change | Capi. | |
---|---|---|
-17.62% | 6.99B | |
-3.93% | 5.1B | |
-6.68% | 4.27B | |
+0.53% | 4.27B | |
-48.27% | 3.45B | |
+7.09% | 2.61B | |
-13.71% | 2.08B | |
-3.40% | 1.67B | |
-12.04% | 1.48B |